• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4593037)   Today's Articles (3978)   Subscriber (49318)
For: Adhikari B, Dongol RM, Baral D, Hewett Y, Shah BK. Pemetrexed and interstitial lung disease. Acta Oncol 2015;55:521-2. [PMID: 26366501 DOI: 10.3109/0284186x.2015.1080859] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Number Cited by Other Article(s)
1
Hordequin L, Eberst G, Guion-Dusserre M, Gondouin A, Barnig C, Westeel V. Immunoglobulins as a treatment modality for corticosteroid-refractory pemetrexed-induced interstitial lung disease, case report. Respir Med Res 2023;83:101000. [PMID: 36812771 DOI: 10.1016/j.resmer.2023.101000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2022] [Revised: 01/22/2023] [Accepted: 01/25/2023] [Indexed: 02/22/2023]
2
China-Pereira N, Campainha S, Furtado A, Conde S, Barroso A. Pemetrexed-induced organizing pneumonia in the treatment of lung adenocarcinoma. REVISTA PORTUGUESA DE PNEUMOLOGIA 2017;23:370-371. [PMID: 29108927 DOI: 10.1016/j.rppnen.2017.09.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2017] [Revised: 08/17/2017] [Accepted: 09/05/2017] [Indexed: 10/18/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA